Details
Stereochemistry | RACEMIC |
Molecular Formula | C7H15Cl2N2O2P.H2O |
Molecular Weight | 279.101 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.ClCCN(CCCl)P1(=O)NCCCO1
InChI
InChIKey=PWOQRKCAHTVFLB-UHFFFAOYSA-N
InChI=1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2
Molecular Formula | C7H15Cl2N2O2P |
Molecular Weight | 261.086 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:55:41 UTC 2023
by
admin
on
Sat Dec 16 17:55:41 UTC 2023
|
Record UNII |
8N3DW7272P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
343611
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
NCI_THESAURUS |
C697
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
IARC | Cyclophosphamide | ||
|
NDF-RT |
N0000175558
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
WHO-VATC |
QL01AA01
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
333711
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
WHO-ATC |
L01AA01
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
333911
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
||
|
LIVERTOX |
NBK548059
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3002
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000078558
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
7154
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
SUB16414MIG
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
CYCLOPHOSPHAMIDE
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | Description: A white, crystalline powder.Solubility: Soluble in water; freely soluble in ethanol (~750 g/l) TS; slightly soluble in ether R.Category: Cytotoxic drug.Storage: Cyclophosphamide should be kept in a tightly closed container and stored at a temperature between 2 and 30 ?C.Additional information. CAUTION: Cyclophosphamide must be handled with care, avoiding contact with the skin and inhalation ofairborne particles. | ||
|
CYCLOPHOSPHAMIDE
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
1157002
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
DTXSID6024888
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
DB00531
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
756711
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
Cyclophosphamide
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
CHEMBL88
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
8N3DW7272P
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
8N3DW7272P
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
D003520
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
4026
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
C405
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
758
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
6055-19-2
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
22420
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY | |||
|
m4013
Created by
admin on Sat Dec 16 17:55:42 UTC 2023 , Edited by admin on Sat Dec 16 17:55:42 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
|
||
|
PARENT -> SALT/SOLVATE |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||